Publication:
Postchemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection: Evaluation of Complications

dc.contributor.authorSompol Permpongkosolen_US
dc.contributor.authorGuilherme C. Limaen_US
dc.contributor.authorChristopher A. Warlicken_US
dc.contributor.authorMohamad E. Allafen_US
dc.contributor.authorIoannis M. Varkarakisen_US
dc.contributor.authorHerman S. Baggaen_US
dc.contributor.authorSahar Kohanimen_US
dc.contributor.authorLouis R. Kavoussien_US
dc.contributor.otherJohns Hopkins Medical Institutionsen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNorth Shore-Long Island Jewish Health Systemen_US
dc.date.accessioned2018-08-24T02:10:33Z
dc.date.available2018-08-24T02:10:33Z
dc.date.issued2007-02-01en_US
dc.description.abstractObjectives: Initial publications on postchemotherapy laparoscopic retroperitoneal lymph node dissection (LRPLND) have described significant intraoperative and postoperative morbidities. This report reviewed the complication rate with additional experience. Methods: A retrospective review of the medical records of 16 consecutive patients who underwent postchemotherapy LRPLND by a single surgeon from September 1996 to September 2005 was performed. The evaluation included tumor type, clinical stage, pathologic stage, and intraoperative and postoperative complications. Results: Postchemotherapy LRPLND was successfully performed in 14 (87.5%) of 16 patients. Seven patients (43.8%) developed complications and 2 (12.5%) required open conversion. The most complications occurred during the postoperative period and were classified as minor. Of the total patient population, 25% had minor postoperative complications. The median hospital stay was 2 days. No patient who underwent the procedure died. All intraoperative complications were vascular injuries and occurred during the first half of the series (1996 to 2000). In the second half of the series (2000 to 2005), no complications during the operative period and no vascular or major complications occurred. No retroperitoneal recurrence was noted during a mean follow-up of 32.7 months (range 5 to 108). One patient developed distant recurrence and underwent successful salvage chemotherapy. Conclusions: Postchemotherapy LRPLND remains a challenging, but feasible, operation. With greater experience, the incidence of complications and morbidity can be reduced. © 2007 Elsevier Inc. All rights reserved.en_US
dc.identifier.citationUrology. Vol.69, No.2 (2007), 361-365en_US
dc.identifier.doi10.1016/j.urology.2006.10.020en_US
dc.identifier.issn15279995en_US
dc.identifier.issn00904295en_US
dc.identifier.other2-s2.0-33847059677en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/25008
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33847059677&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePostchemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection: Evaluation of Complicationsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33847059677&origin=inwarden_US

Files

Collections